[1]
Henrique Ferracioli Alvarenga, G. et al. 2022. ADVANCES AND BENEFITS OF NANOTECHNOLOGY IN THE DEVELOPMENT OF SARS-COV-2 VACCINES: INTEGRATIVE REVIEW. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218. 3, 2 (Jan. 2022), e321111. DOI:https://doi.org/10.47820/recima21.v3i2.1111.